Evidence map›Paper›PMID 26850269›Full record

ArticleEuropean journal of nutrition2017

Dietary and lifestyle determinants of acrylamide and glycidamide hemoglobin adducts in non-smoking postmenopausal women from the EPIC cohort.

Mireia Obón-Santacana, Leila Lujan-Barroso, Heinz Freisling, Claire Cadeau, Guy Fagherazzi, Marie-Christine Boutron-Ruault, Rudolf Kaaks, Renée T Fortner, Heiner Boeing, J Ramón Quirós and 22 more

Open access · greenAbstract read
In one paragraph

Article in European journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Assessment of the genotoxicity of acrylamide.EFSA journal. European Food Safety Authority · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 10 countries.

Mireia Obón-SantacanaUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (ICO-IDIBELL), Avda Gran Via Barcelona 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
Leila Lujan-BarrosoUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (ICO-IDIBELL), Avda Gran Via Barcelona 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
Heinz FreislingDietary Exposure Assessment Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon, France.
Claire CadeauCentre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, Inserm, 94805, Villejuif, France.
Guy FagherazziCentre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, Inserm, 94805, Villejuif, France.
Marie-Christine Boutron-RuaultCentre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, Inserm, 94805, Villejuif, France.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany.
Renée T FortnerDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany.
Heiner BoeingDepartment of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114/116, 14558, Nuthetal, Germany.
J Ramón QuirósPublic Health and Participation Directorate, Ciriaco Miguel Vigil 9, 33009, Asturias, Spain.
Esther Molina-MontesEscuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs. GRANADA, Hospitales Universitarios de Granada, Universidad de Granada, Cuesta del Observatorio, 4, Campus Universitario de Cartuja, 18080, Granada, Spain.
Saioa ChamosaPublic Health Division of Gipuzkoa-BIODONOSTIA, Basque Regional Health Department, Avda. Navarra, 4, 20013, San Sebastián, Spain.
José María Huerta CastañoCIBER Epidemiology and Public Health CIBERESP, Melchor Fernández Almagro 3-5, 28029, Madrid, Spain.
Eva ArdanazCIBER Epidemiology and Public Health CIBERESP, Melchor Fernández Almagro 3-5, 28029, Madrid, Spain.
Kay-Tee KhawUniversity of Cambridge School of Clinical Medicine, Robinson Way, Cambridge, CB2 0SR, UK.
Nick WarehamMRC Epidemiology Unit, University of Cambridge, 184 Hills Road, Cambridge, CB2 8PQ, UK.
Tim KeyCancer Epidemiology Unit, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.
Antonia TrichopoulouHellenic Health Foundation, 13 Kaisareias Street, 115 27, Athens, Greece.
Pagona LagiouDepartment of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, 75 M. Asias Street, Goudi, 115 27, Athens, Greece.
Androniki NaskaHellenic Health Foundation, 13 Kaisareias Street, 115 27, Athens, Greece.
Domenico PalliMolecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Ponte Nuovo, Via delle Oblate n.2, 50141, Florence, Italy.
Sara GrioniEpidemiology and Prevention Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.
Rosario TuminoCancer Registry and Histopathology Unit, "Civic-M.P.Arezzo" Hospital, Via Civile, 97100, Ragusa, Italy.
Paolo VineisHuman Genetics Foundation (HuGeF), Via Nizza 52, 10126, Turin, Italy.
Maria Santucci De MagistrisDepartment of Clinical and Experimental Medicine, Federico II University, Corso Umberto I, 40bis, 80138, Naples, Italy.
H B Bueno-de-MesquitaDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK.
Petra H PeetersDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK.
Maria WennbergDepartment of Public Health and Clinical Medicine, Umeå University, 1A, 9 tr, Kirurgcentrum, 952, 901 85, Umeå, Sweden.
Ingvar A BergdahlDepartment of Biobank Research, Umeå University, 1A, 9 tr, Kirurgcentrum, 952, 901 85, Umeå, Sweden.
Hubert VesperCenters for Disease Control and Prevention, MS F25, 4770 Buford Hwy NE, Atlanta, GA, 30341, USA.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK.
Eric J DuellUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (ICO-IDIBELL), Avda Gran Via Barcelona 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain. eduell@iconcologia.net.
Institut d'Investigació Biomédica de Bellvitge · ESNational and Kapodistrian University of Athens · GRUmeå University · SEAzienda Usl 8 Arezzo · ITBasque Government · ESCenters for Disease Control and Prevention · USCentre de recherche en Epidémiologie et Santé des Populations · FRCentre International de Recherche sur le Cancer · FRComplejo Hospitalario Universitario de Granada · ESFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Cancer Research Center · DEGerman Institute of Human Nutrition · DEGovernment of Spain · ESHeidelberg University · DEHellenic Health Foundation · GRImperial College London · GBInserm · FRInstitut Català d'Oncologia · ESItalian institute for Genomic Medicine · IT

Funding

Cancer Research UK 14136Cancer Research UK 16491Medical Research Council MC_U106179471Medical Research Council MC_UU_12015/1Medical Research Council MR/N003284/1World Health Organization 001
6 · The paper itself

Abstract

purposeAcrylamide was classified as 'probably carcinogenic' to humans in 1994 by the International Agency for Research on Cancer. In 2002, public health concern increased when acrylamide was identified in starchy, plant-based foods, processed at high temperatures. The purpose of this study was to identify which food groups and lifestyle variables were determinants of hemoglobin adduct concentrations of acrylamide (HbAA) and glycidamide (HbGA) in 801 non-smoking postmenopausal women from eight countries in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

methodsBiomarkers of internal exposure were measured in red blood cells (collected at baseline) by high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS/MS) . In this cross-sectional analysis, four dependent variables were evaluated: HbAA, HbGA, sum of total adducts (HbAA + HbGA), and their ratio (HbGA/HbAA). Simple and multiple regression analyses were used to identify determinants of the four outcome variables. All dependent variables (except HbGA/HbAA) and all independent variables were log-transformed (log

resultsThe main food group determinants of HbAA, HbGA, and HbAA + HbGA were biscuits, crackers, and dry cakes. Alcohol intake and body mass index were identified as the principal determinants of HbGA/HbAA. The total percent variation in HbAA, HbGA, HbAA + HbGA, and HbGA/HbAA explained in this study was 30, 26, 29, and 13 %, respectively.

conclusionsDietary and lifestyle factors explain a moderate proportion of acrylamide adduct variation in non-smoking postmenopausal women from the EPIC cohort.

Indexed as

DietLife StyleAcrylamideCase-Control StudiesCross-Sectional StudiesEpoxy CompoundsFemaleHemoglobinsHumansLinear ModelsMiddle AgedNeoplasmsNutrition AssessmentPostmenopauseSurveys and QuestionnairesTandem Mass SpectrometryAcrylamideEpoxy CompoundsglycidamideHemoglobinsAcrylamideBiomarkersDietGlycidamideHemoglobin adductsNutrition

Identifiers

PMID26850269
PMCPMC5576523
OpenAlexW2252450578

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.